Ulthera develops the Ulthera® System, an FDA-approved ultrasound device for non-invasive face and neck aesthetic treatments, with a specific indication for eyebrow lift. The system has been available in Europe and Asia since 2008 through a network of distributors. Within the U.S. the company operates a direct sales and marketing organization focused on plastic surgeons, facial plastic surgeons and dermatologists. The company plans to continue developing its platform technology and to invest in product development. Ulthera also intends to expand its organization. Financially, the company completed a $10.5M Series C venture round to support these plans.

Total raised

$11M

Funding rounds

1

Latest round

Series C

Latest activity

Feb 2011